Erste Group Bank Lowers Earnings Estimates for CME Group

Posted by Brenda Bartman on Jul 22nd, 2026

CME Group Inc. (NASDAQ:CME – Free Report) – Stock analysts at Erste Group Bank reduced their FY2026 earnings per share estimates for CME Group in a report issued on Wednesday, July 15th. Erste Group Bank analyst H. Engel now expects that the financial services provider will earn $12.21 per share for the year, down from their previous estimate of $12.24. Erste Group Bank has a “Hold” rating on the stock. The consensus estimate for CME Group’s current full-year earnings is $12.18 per share. Erste Group Bank also issued estimates for CME Group’s FY2027 earnings at $12.94 EPS.

CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same period in the previous year, the company posted $2.80 earnings per share. The business’s revenue was up 14.5% on a year-over-year basis.

A number of other equities research analysts have also recently issued reports on CME. Barclays lowered their price objective on CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 9th. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 12th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research note on Thursday, April 23rd. Morgan Stanley lowered their price target on shares of CME Group from $353.00 to $324.00 and set an “overweight” rating on the stock in a research report on Friday, July 10th. Finally, TD Cowen dropped their price target on shares of CME Group from $323.00 to $273.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. Twelve analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $292.12.

Read Our Latest Research Report on CME

CME Group Stock Down 3.1%

CME stock opened at $237.41 on Monday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $86.03 billion, a price-to-earnings ratio of 20.26, a PEG ratio of 3.05 and a beta of 0.25. CME Group has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The stock has a fifty day moving average of $256.83 and a 200-day moving average of $281.68.

Hedge Funds Weigh In On CME Group

Several hedge funds have recently bought and sold shares of CME. Norges Bank bought a new position in CME Group in the 4th quarter valued at $1,523,241,000. Victory Capital Management Inc. grew its position in shares of CME Group by 746.4% during the 4th quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock valued at $559,720,000 after purchasing an additional 1,807,491 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of CME Group by 39.1% in the first quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider’s stock worth $1,187,290,000 after purchasing an additional 1,130,587 shares during the period. Life Cycle Investment Partners Ltd bought a new position in shares of CME Group in the fourth quarter worth $217,656,000. Finally, Viking Global Investors LP purchased a new stake in shares of CME Group in the second quarter worth $164,648,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insiders Place Their Bets

In related news, Director William R. Shepard purchased 325 shares of the firm’s stock in a transaction dated Thursday, June 25th. The shares were purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer directly owned 55,630 shares in the company, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is owned by corporate insiders.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Tuesday, June 9th were issued a dividend of $1.30 per share. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.2%. CME Group’s dividend payout ratio is 44.37%.

About CME Group

(Get Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.